Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 9401–9420 of 17,529 recalls

February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Amitriptyline HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estriol USP (Micronized) (Yam) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Imiquimod USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Fluticasone propionate USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Anastrozole USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ketoprofen USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Diphenhydramine HCl USP f (or prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Progesterone USP (Micronized) (Yam) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Fluconazole USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Ascorbic Acid USP

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Itraconazole USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levocetirizine Dihydrochloride for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 7, 2018· Pfizer Inc.

Recalled Item: Hydromorphone

The Issue: Non-Sterility: Confirmed customer complaints of glass product container

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
February 7, 2018· Pfizer Inc.

Recalled Item: Hydromorphone

The Issue: Non-Sterility: Confirmed customer complaints of glass product container

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
February 7, 2018· Webrx dba RxPalace.com

Recalled Item: BonaDur For Men (lidocaine) spray

The Issue: CGMP Deviations: not manufactured according to current good

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 5, 2018· PharMEDium Services, LLC

Recalled Item: 0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride

The Issue: Lack of assurance of sterility: Three lots were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 5, 2018· Genentech, Inc.

Recalled Item: Klonopin (clonazepam) 0.5 mg Tablets

The Issue: Labeling: Not Elsewhere Classified: Schedule IV controlled substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 5, 2018· Sun Pharmaceutical Industries, Inc.

Recalled Item: Azelastine HCl Nasal Solution (Nasal Spray) 0.1% (137 mcg per spray)

The Issue: Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 5, 2018· Teva Pharmaceuticals USA

Recalled Item: Fluoxetine Tablets USP

The Issue: Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 5, 2018· PharMEDium Services, LLC

Recalled Item: 100 mcg / mL Phenylephrine HCl (Preservative Free) Injection

The Issue: Lack of assurance of sterility: Three lots were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund